非インスリン糖尿病治療薬市場は、2022年から2027年の間に312億5,155万米ドル成長すると予測されており、予測期間中にCAGRは10.82%で加速します。非インスリン糖尿病治療薬市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、2 型糖尿病患者の増加、6 〜 19 歳および 35 〜 50 歳の糖尿病有病率の増加、および最近の製品承認によって牽引されています。
この調査は、治療法の革新が、今後数年間の非インスリン糖尿病治療薬市場の成長を促進する主な理由の1つであることを特定しています。また、ベンダー間の戦略的提携と配合剤の需要の増加により、市場での大きな需要が見込まれるでしょう。
堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、非インスリン糖尿病治療薬市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global non-insulin diabetes therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global non-insulin diabetes therapeutics market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 DPP4 inhibitors - Market size and forecast 2022-2027
Exhibit 34: Chart on DPP4 inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on DPP4 inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on DPP4 inhibitors - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on DPP4 inhibitors - Year-over-year growth 2022-2027 (%)
6.4 GLP-1 receptor agonists - Market size and forecast 2022-2027
Exhibit 38: Chart on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
6.5 SGLT2 inhibitors - Market size and forecast 2022-2027
Exhibit 42: Chart on SGLT2 inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on SGLT2 inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on SGLT2 inhibitors - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on SGLT2 inhibitors - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Type
Exhibit 50: Market opportunity by Type ($ million)
Exhibit 51: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 52: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 56: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 60: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 64: Market opportunity by Distribution Channel ($ million)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 India - Market size and forecast 2022-2027
Exhibit 103: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on India - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 AstraZeneca PLC
Exhibit 120: AstraZeneca PLC - Overview
Exhibit 121: AstraZeneca PLC - Product / Service
Exhibit 122: AstraZeneca PLC - Key news
Exhibit 123: AstraZeneca PLC - Key offerings
12.5 Better Therapeutics Inc.
Exhibit 124: Better Therapeutics Inc. - Overview
Exhibit 125: Better Therapeutics Inc. - Product / Service
Exhibit 126: Better Therapeutics Inc. - Key news
Exhibit 127: Better Therapeutics Inc. - Key offerings
12.6 Boehringer Ingelheim International GmbH
Exhibit 128: Boehringer Ingelheim International GmbH - Overview
Exhibit 129: Boehringer Ingelheim International GmbH - Business segments
Exhibit 130: Boehringer Ingelheim International GmbH - Key news
Exhibit 131: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 132: Boehringer Ingelheim International GmbH - Segment focus
12.7 Eli Lilly and Co.
Exhibit 133: Eli Lilly and Co. - Overview
Exhibit 134: Eli Lilly and Co. - Product / Service
Exhibit 135: Eli Lilly and Co. - Key news
Exhibit 136: Eli Lilly and Co. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
Exhibit 142: GlaxoSmithKline Plc - Overview
Exhibit 143: GlaxoSmithKline Plc - Business segments
Exhibit 144: GlaxoSmithKline Plc - Key news
Exhibit 145: GlaxoSmithKline Plc - Key offerings
Exhibit 146: GlaxoSmithKline Plc - Segment focus
12.10 Johnson and Johnson Services Inc.
Exhibit 147: Johnson and Johnson Services Inc. - Overview
Exhibit 148: Johnson and Johnson Services Inc. - Business segments
Exhibit 149: Johnson and Johnson Services Inc. - Key news
Exhibit 150: Johnson and Johnson Services Inc. - Key offerings
Exhibit 151: Johnson and Johnson Services Inc. - Segment focus
12.11 Merck KGaA
Exhibit 152: Merck KGaA - Overview
Exhibit 153: Merck KGaA - Business segments
Exhibit 154: Merck KGaA - Key news
Exhibit 155: Merck KGaA - Key offerings
Exhibit 156: Merck KGaA - Segment focus
12.12 Novartis AG
Exhibit 157: Novartis AG - Overview
Exhibit 158: Novartis AG - Business segments
Exhibit 159: Novartis AG - Key offerings
Exhibit 160: Novartis AG - Segment focus
12.13 Novo Nordisk AS
Exhibit 161: Novo Nordisk AS - Overview
Exhibit 162: Novo Nordisk AS - Business segments
Exhibit 163: Novo Nordisk AS - Key offerings
Exhibit 164: Novo Nordisk AS - Segment focus
12.14 Pfizer Inc.
Exhibit 165: Pfizer Inc. - Overview
Exhibit 166: Pfizer Inc. - Product / Service
Exhibit 167: Pfizer Inc. - Key news
Exhibit 168: Pfizer Inc. - Key offerings
12.15 Sanofi SA
Exhibit 169: Sanofi SA - Overview
Exhibit 170: Sanofi SA - Business segments
Exhibit 171: Sanofi SA - Key news
Exhibit 172: Sanofi SA - Key offerings
Exhibit 173: Sanofi SA - Segment focus
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 174: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 175: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 176: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 177: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 The Cleveland Clinic Foundation
Exhibit 178: The Cleveland Clinic Foundation - Overview
Exhibit 179: The Cleveland Clinic Foundation - Product / Service
Exhibit 180: The Cleveland Clinic Foundation - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 181: Inclusions checklist
Exhibit 182: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 183: Currency conversion rates for US$
13.4 Research methodology
Exhibit 184: Research methodology
Exhibit 185: Validation techniques employed for market sizing
Exhibit 186: Information sources
13.5 List of abbreviations
Exhibit 187: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global non-insulin diabetes therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on DPP4 inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on DPP4 inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on DPP4 inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on DPP4 inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on GLP-1 receptor agonists - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on GLP-1 receptor agonists - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on SGLT2 inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on SGLT2 inhibitors - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on SGLT2 inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on SGLT2 inhibitors - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Type ($ million)
Exhibits51: Data Table on Market opportunity by Type ($ million)
Exhibits52: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits53: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Distribution Channel
Exhibits55: Data Table on Comparison by Distribution Channel
Exhibits56: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Distribution Channel ($ million)
Exhibits65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: AstraZeneca PLC - Overview
Exhibits121: AstraZeneca PLC - Product / Service
Exhibits122: AstraZeneca PLC - Key news
Exhibits123: AstraZeneca PLC - Key offerings
Exhibits124: Better Therapeutics Inc. - Overview
Exhibits125: Better Therapeutics Inc. - Product / Service
Exhibits126: Better Therapeutics Inc. - Key news
Exhibits127: Better Therapeutics Inc. - Key offerings
Exhibits128: Boehringer Ingelheim International GmbH - Overview
Exhibits129: Boehringer Ingelheim International GmbH - Business segments
Exhibits130: Boehringer Ingelheim International GmbH - Key news
Exhibits131: Boehringer Ingelheim International GmbH - Key offerings
Exhibits132: Boehringer Ingelheim International GmbH - Segment focus
Exhibits133: Eli Lilly and Co. - Overview
Exhibits134: Eli Lilly and Co. - Product / Service
Exhibits135: Eli Lilly and Co. - Key news
Exhibits136: Eli Lilly and Co. - Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. - Overview
Exhibits138: F. Hoffmann La Roche Ltd. - Business segments
Exhibits139: F. Hoffmann La Roche Ltd. - Key news
Exhibits140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits142: GlaxoSmithKline Plc - Overview
Exhibits143: GlaxoSmithKline Plc - Business segments
Exhibits144: GlaxoSmithKline Plc - Key news
Exhibits145: GlaxoSmithKline Plc - Key offerings
Exhibits146: GlaxoSmithKline Plc - Segment focus
Exhibits147: Johnson and Johnson Services Inc. - Overview
Exhibits148: Johnson and Johnson Services Inc. - Business segments
Exhibits149: Johnson and Johnson Services Inc. - Key news
Exhibits150: Johnson and Johnson Services Inc. - Key offerings
Exhibits151: Johnson and Johnson Services Inc. - Segment focus
Exhibits152: Merck KGaA - Overview
Exhibits153: Merck KGaA - Business segments
Exhibits154: Merck KGaA - Key news
Exhibits155: Merck KGaA - Key offerings
Exhibits156: Merck KGaA - Segment focus
Exhibits157: Novartis AG - Overview
Exhibits158: Novartis AG - Business segments
Exhibits159: Novartis AG - Key offerings
Exhibits160: Novartis AG - Segment focus
Exhibits161: Novo Nordisk AS - Overview
Exhibits162: Novo Nordisk AS - Business segments
Exhibits163: Novo Nordisk AS - Key offerings
Exhibits164: Novo Nordisk AS - Segment focus
Exhibits165: Pfizer Inc. - Overview
Exhibits166: Pfizer Inc. - Product / Service
Exhibits167: Pfizer Inc. - Key news
Exhibits168: Pfizer Inc. - Key offerings
Exhibits169: Sanofi SA - Overview
Exhibits170: Sanofi SA - Business segments
Exhibits171: Sanofi SA - Key news
Exhibits172: Sanofi SA - Key offerings
Exhibits173: Sanofi SA - Segment focus
Exhibits174: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits175: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits176: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits177: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits178: The Cleveland Clinic Foundation - Overview
Exhibits179: The Cleveland Clinic Foundation - Product / Service
Exhibits180: The Cleveland Clinic Foundation - Key offerings
Exhibits181: Inclusions checklist
Exhibits182: Exclusions checklist
Exhibits183: Currency conversion rates for US$
Exhibits184: Research methodology
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Information sources
Exhibits187: List of abbreviations
